SANA
Income statement / Annual
Last year (2025), Sana Biotechnology Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Sana Biotechnology Inc's net income was -$244.17 M.
See Sana Biotechnology Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$12.75 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10.17 M
|
$3.92 M
|
$1.00 K
|
| Gross Profit |
-$12.75 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$10.17 M
|
-$3.92 M
|
-$1.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$131.98 M
|
$208.68 M
|
$219.84 M
|
$201.00 M
|
$306.50 M
|
$122.68 M
|
$119.38 M
|
$4.01 M
|
| General & Administrative Expenses |
$44.30 M
|
$64.04 M
|
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$8.41 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$44.30 M
|
$64.04 M
|
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$4.21 M
|
| Other Expenses |
$1.93 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$178.21 M
|
$272.72 M
|
$293.14 M
|
$272.56 M
|
$356.91 M
|
$150.95 M
|
$141.15 M
|
$8.22 M
|
| Cost And Expenses |
$190.96 M
|
$272.72 M
|
$293.14 M
|
$272.56 M
|
$356.91 M
|
$161.12 M
|
$141.15 M
|
$8.22 M
|
| Interest Income |
$3.85 M
|
$10.47 M
|
$9.94 M
|
$3.76 M
|
$676.00 K
|
$747.00 K
|
$2.86 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$12.75 M
|
$17.39 M
|
$24.56 M
|
$15.63 M
|
$11.07 M
|
$10.17 M
|
$3.92 M
|
$1.00 K
|
| EBITDA |
-$178.21 M |
-$255.33 M |
-$268.58 M |
-$256.94 M |
-$345.84 M |
-$287.03 M |
-$138.90 M |
-$13.25 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$53.21 M
|
$5.96 M
|
$9.89 M
|
$3.09 M
|
$981.00 K
|
-$136.08 M
|
$2.83 M
|
-$5.03 M
|
| Income Before Tax |
-$244.17 M
|
-$266.76 M
|
-$283.26 M
|
-$269.48 M
|
-$355.93 M
|
-$297.21 M
|
-$138.33 M
|
-$13.25 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$11.90 M
|
-$7.55 M
|
$0.00
|
| Net Income |
-$244.17 M
|
-$266.76 M
|
-$283.26 M
|
-$269.48 M
|
-$355.93 M
|
-$285.31 M
|
-$130.78 M
|
-$13.25 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.96 |
-1.16 |
-1.46 |
-1.43 |
-2.14 |
-1.63 |
-0.7 |
-0.0707 |
| EPS Diluted |
-0.96 |
-1.16 |
-1.46 |
-1.43 |
-2.14 |
-1.63 |
-0.7 |
-0.0707 |
| Weighted Average Shares Out |
$253.23 M
|
$230.89 M
|
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Weighted Average Shares Out Diluted |
$253.23 M
|
$230.89 M
|
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Link |
|
|
|
|
|
|
|
|
